{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:02:44Z","timestamp":1775602964339,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010597","name":"Capsugel Japan Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010597","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ejpb.2020.07.032","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T21:06:45Z","timestamp":1596748005000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["An enteric polymer mitigates the effects of gastric pH on oral absorption of poorly soluble weak acid drugs from supersaturable formulations: A case study with dantrolene"],"prefix":"10.1016","volume":"155","author":[{"given":"Makoto","family":"Kataoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyako","family":"Umesaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Higashino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.07.032_b0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0163-7258(89)90019-3","article-title":"Effects of food on drug absorption","volume":"43","author":"Welling","year":"1989","journal-title":"Pharmacol. Ther."},{"issue":"Suppl 2","key":"10.1016\/j.ejpb.2020.07.032_b0010","first-page":"77S","article-title":"The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation","volume":"19","author":"Hirtz","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.07.032_b0015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-114-9-755","article-title":"Increased gastric pH and the bioavailability of fluconazole and ketoconazole","volume":"114","author":"Blum","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejpb.2020.07.032_b0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1023\/A:1018918316253","article-title":"pH-related changes in the absorption of dipyridamole in the elderly","volume":"11","author":"Russell","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.07.032_b0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4269\/ajtmh.2000.63.270","article-title":"Effect of dose increase or cimetidine co-administration on albendazole bioavailability","volume":"63","author":"Schipper","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejpb.2020.07.032_b0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpharm.2007.04.002","article-title":"Pharmacokinetics of gefitinib in humans: the influence of gastrointestinal factors","volume":"341","author":"Bergman","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.07.032_b0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1099-1069(1998030)16:1<33::AID-HON620>3.0.CO;2-9","article-title":"Plasma concentration of itraconazole in patients receiving chemotherapy for hematological malignancies: the effect of famotidine on the absorption of itraconazole","volume":"16","author":"Kanda","year":"1998","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.ejpb.2020.07.032_b0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1592\/phco.26.3.341","article-title":"Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers","volume":"6","author":"Tomilo","year":"2006","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.ejpb.2020.07.032_b0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.07.032_b0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1011984216775","article-title":"Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms","volume":"15","author":"Dressman","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.07.032_b0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/00365526909180618","article-title":"A screening technique for the detection of achlorhydria using the Heidelberg capsule","volume":"4","author":"Williamson","year":"1969","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2020.07.032_b0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2036.1990.tb00013.x","article-title":"Intravenous pentagastrin can induce the illusion of \u2019tolerance\u2019 to a single dose of an H2-blocker in man","volume":"1","author":"Nwokolo","year":"1990","journal-title":"Aliment. Pharmacol. Ther. Suppl."},{"key":"10.1016\/j.ejpb.2020.07.032_b0065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/00365529309096067","article-title":"Effect of Once Daily Intravenous and Oral Omeprazole on 24-hour Intragastric Acidity in Healthy Subjects","volume":"28","author":"Cederberg","year":"1993","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2020.07.032_b0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2133\/dmpk.DMPK-12-RG-139","article-title":"New dipyridamole salt with improved dissolution and oral bioavailability under hypochlorhydric conditions","volume":"28","author":"Taniguchi","year":"2012","journal-title":"Drug. Metab. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2020.07.032_b0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijpharm.2003.07.010","article-title":"Establishment of new preparation method for solid dispersion formulation of tacrolimus","volume":"267","author":"Yamashita","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.07.032_b0080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/jps.21451","article-title":"Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption","volume":"98","author":"Gao","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.07.032_b0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejps.2015.05.015","article-title":"Improved dissolution and absorption of ketoconazole in the presence of organic acids as pH-modifiers","volume":"76","author":"Adachi","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.07.032_b0090","unstructured":"EMEA, Guideline on the investigation of bioequivalence, 2010. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-investigation-bioequivalence-rev1_en.pdf (accessed on March 6, 2020)."},{"key":"10.1016\/j.ejpb.2020.07.032_b0095","unstructured":"(CDER) FDA, Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system - Guidance for industry. FDA, 2017. Available at: https:\/\/www.fda.gov\/media\/70963\/download (accessed on March 6, 2020)."},{"key":"10.1016\/j.ejpb.2020.07.032_b0100","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/bdd.1800","article-title":"In silico prediction of drug dissolution and absorption with variation in intestinal pHfor BCS class II weak acid drugs: Ibuprofen and ketoprofen","volume":"33","author":"Tsume","year":"2012","journal-title":"Biopharm. Drug. Dispos."},{"key":"10.1016\/j.ejpb.2020.07.032_b0105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1208\/s12248-008-9023-x","article-title":"Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds","volume":"10","author":"Tubic-Grozdanis","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2020.07.032_b0110","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1023\/B:PHAM.0000041450.25106.c8","article-title":"Identification of biowaivers among Class II drugs: Theoretical justification and practical examples","volume":"21","author":"Rinaki","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.07.032_b0115","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/jps.10511","article-title":"Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability","volume":"92","author":"Gao","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.07.032_b0120","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/10837450.2014.882938","article-title":"Amorphous solid dispersion with increased gastric solubility in tandem with oral disintegrating tablets: a successful approach to improve the bioavailability of atorvastatin","volume":"20","author":"Salmani","year":"2015","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2020.07.032_b0125","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ijpharm.2016.07.068","article-title":"Pharmaceutical development of an oral tablet formulation containing a spray dried amorphous solid dispersion of docetaxel or paclitaxel","volume":"511","author":"Sawicki","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.07.032_b0130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2013.04.006","article-title":"Preparation of fenofibrate solid dispersion using electrospray deposition and improvement in oral absorption by instantaneous post-heating of the formulation","volume":"450","author":"Kawakami","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.07.032_b0135","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/j.1552-4604.1996.tb04153.x","article-title":"Metoclopramide increases the bioavailability of dantrolene in spinal cord injury","volume":"36","author":"Gilman","year":"1996","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.07.032_b0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejpb.2016.02.002","article-title":"Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution\/permeation system reflecting the gastric dissolution process","volume":"101","author":"Kataoka","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.07.032_b0145","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bbrc.2006.08.088","article-title":"Expression of HSP72 in the gastric mucosa is regulated by gastric acid in rats-correlation of HSP72 expression with mucosal protection","volume":"349","author":"Wada","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejpb.2020.07.032_b0150","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/jps.20691","article-title":"Effect of food intake on the oral absorption of poorly water-soluble drugs: in vitro assessment of drug dissolution and permeation assay system","volume":"95","author":"Kataoka","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.07.032_b0155","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jps.24647","article-title":"Gastrointestinal Behavior of Weakly Acidic BCS Class II Drugs in Man-Case Study of Diclofenac Potassium","volume":"105","author":"Van Den Abeele","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.07.032_b0160","unstructured":"Voltaren\u00ae (diclofenac sodium, Novartis, Basel, Switzerland) Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/019201s038lbl.pdf (accessed on March 6, 2020)."},{"key":"10.1016\/j.ejpb.2020.07.032_b0165","unstructured":"Cataflam\u00ae (diclofenac potassium, Novartis, Basel, Switzerland) Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/020142s021s022lbl.pdf (accessed on March 6, 2020)."},{"issue":"34","key":"10.1016\/j.ejpb.2020.07.032_b0170","first-page":"243","article-title":"Lack of pantoprazole drug interactions in man: an updated review","volume":"1996","author":"Steinijans","year":"1996","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2020.07.032_b0175","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejpb.2012.12.001","article-title":"An in vitro-in silico-in vivo approach to predicting the oral pharmacokinetic profile of salts of weak acids: case example dantrolene","volume":"84","author":"Kambayashi","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.07.032_b0180","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejpb.2016.04.004","article-title":"Characterizing the dissolution profiles of supersaturable salts, cocrystals, and solvates to enhance in vivo oral absorption","volume":"103","author":"Hisada","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.07.032_b0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejpb.2011.01.001","article-title":"Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products","volume":"78","author":"Liu","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.07.032_b0190","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1248\/bpb1978.11.563","article-title":"Gastric emptying rates of drug preparations. I. Effects of size of dosage forms, food and species on gastric emptying rates","volume":"11","author":"Kaniwa","year":"1988","journal-title":"J. Pharmacobiodyn."},{"key":"10.1016\/j.ejpb.2020.07.032_b0195","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1248\/cpb.40.3343","article-title":"Gastric emptying rate of drug preparations. III, Effects of size of enteric micro-capsules with mean diameters ranging from 0.1 to 1.1 mm in man","volume":"40","author":"Sugito","year":"1992","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2020.07.032_b0200","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/A:1011962501270","article-title":"Drug marker absorption in relation to pellet size, gastric motility and viscous meals in humans","volume":"15","author":"Rhie","year":"1998","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120302356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120302356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:37:38Z","timestamp":1760546258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120302356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":40,"alternative-id":["S0939641120302356"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.07.032","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An enteric polymer mitigates the effects of gastric pH on oral absorption of poorly soluble weak acid drugs from supersaturable formulations: A case study with dantrolene","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}